The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.
DENTSPLY SIRONA Inc. (XRAY)
Common Stock · Currency in USD · XNAS
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Company Info
SIC3843
Composite FIGIBBG000BX57K1
CIK0000818479
IPOMay 12, 1983
Sectordental equipment & supplies
Highlights
Market Cap$2.32B
EPS-$8.56
P/E Ratio-1.36
Revenue$3.68B
Gross Profit$1.76B
Net Income-$1.71B
Employees14,000
WSO199,749,333
Phone844-546-3722
Related Tickers
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in DENTSPLY SIRONA Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
DENTSPLY SIRONA Inc. (XRAY) has returned 1.39% so far this year and -10.95% over the past 12 months. Looking at the last ten years, XRAY has achieved an annualized return of -15.35%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
XRAY
1M-11.89%
6M-11.83%
YTD1.39%
1Y-10.95%
5Y-28.96%
10Y-15.35%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of DENTSPLY SIRONA Inc. (XRAY) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.72% | 18.48% | -19.36% | -0.17% | ||||||||
| 2025 | 3.56% | -14.47% | -10.16% | -6.77% | 13.90% | 0.13% | -9.43% | 0.56% | -9.62% | -1.02% | -9.86% | 2.42% |
| 2024 | -1.75% | -6.52% | 0.61% | -9.66% | -6.91% | -11.07% | 8.52% | -7.23% | 7.98% | -14.60% | -14.94% | -2.77% |
| 2023 | 15.02% | 3.48% | 2.03% | 6.83% | -13.42% | 6.86% | 4.53% | -9.69% | -8.69% | -10.77% | 4.41% | 12.27% |
| 2022 | -4.14% | 1.52% | -9.12% | -19.13% | -0.98% | -10.20% | 1.74% | -9.43% | -13.12% | 7.72% | 9.72% | 4.67% |
| 2021 | -0.06% | -1.56% | 9.64% | 6.80% | -1.41% | -5.96% | 3.66% | -6.81% | -6.46% | -2.12% | -14.89% | 13.26% |
| 2020 | -1.46% | -12.45% | -21.67% | 14.61% | 11.53% | -4.71% | 1.18% | 0.36% | -2.50% | 7.25% | 7.00% | 1.47% |
| 2019 | 13.50% | -0.93% | 5.53% | 2.69% | 5.65% | 8.01% | -7.02% | -3.96% | 2.90% | 2.26% | 2.87% | 0.09% |
| 2018 | -7.86% | -7.42% | -9.34% | 0.48% | -12.78% | -0.39% | 10.19% | -16.03% | -5.22% | -9.04% | 9.00% | -1.95% |
| 2017 | -2.28% | 12.03% | -2.10% | 1.23% | 0.11% | 1.73% | -4.77% | -8.92% | 5.54% | 5.29% | 9.19% | -1.75% |
| 2016 | -2.95% | 3.98% | -0.19% | 3.04% | -3.97% | -3.59% | -2.54% | -0.77% | -1.15% |
Performance Indicators
The charts below present risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of XRAY compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current DENTSPLY SIRONA Inc. volatility is 2.99%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 5.43B | 5.75B | 7.37B | 7.64B | 9.22B | 9.34B | 8.60B | 8.69B | 10.37B | 11.66B | 48.22B | 36.99B | 34.67B | 32.94B | 29.95B | 19.60B |
| Equity Attributable To Parent (USD) | 1.34B | 1.94B | 3.29B | 3.81B | 5.04B | 4.97B | 5.09B | 5.12B | 6.62B | 8.11B | 23.69B | 23.38B | 22.39B | 19.02B | 16.90B | 11.63B |
| Equity Attributable To Noncontrolling Interest (USD) | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 3.00M | 2.40M | 11.90M | 11.60M | 11.60M | 73.70M | 71.70M | 66.10M | 67.40M | 66.99M | - |
| Equity (USD) | 1.34B | 1.94B | 3.29B | 3.81B | 5.04B | 4.97B | 5.09B | 5.13B | 6.63B | 8.13B | 23.76B | 23.45B | 22.45B | 19.08B | 16.97B | 11.63B |
| Commitments and Contingencies (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Non-current Liabilities (USD) | 470.00M | 473.00M | 742.00M | 790.00M | 1.07B | 771.00M | 1.07B | 960.70M | 1.17B | 1.23B | 5.42B | 4.67B | 4.19B | 4.31B | 3.50B | - |
| Long-term Debt (USD) | 2.28B | 1.75B | 1.91B | 1.87B | 1.92B | 2.28B | 1.44B | 1.58B | 1.63B | 1.53B | 12.87B | 3.47B | 3.50B | 5.34B | 5.31B | - |
| Noncurrent Liabilities (USD) | 2.75B | 2.22B | 2.65B | 2.66B | 2.99B | 3.06B | 2.51B | 2.54B | 2.79B | 2.76B | 18.29B | 8.15B | 7.69B | 9.65B | 8.81B | 5.20B |
| Other Current Liabilities (USD) | 872.00M | 1.22B | 959.00M | 735.00M | 746.00M | 870.00M | 508.80M | 729.40M | 670.10M | 548.00M | 5.20B | 4.49B | - | - | - | - |
| Wages (USD) | 171.00M | 125.00M | 161.00M | 156.00M | 172.00M | 142.00M | 178.80M | - | - | - | 968.70M | 911.40M | - | - | - | - |
| Accounts Payable (USD) | 300.00M | 241.00M | 305.00M | 279.00M | 268.00M | 305.00M | 307.90M | 283.90M | 284.40M | 223.00M | - | - | - | - | - | - |
| Current Liabilities (USD) | 1.34B | 1.59B | 1.43B | 1.17B | 1.19B | 1.32B | 995.50M | 1.01B | 954.50M | 771.00M | 6.17B | 5.40B | 4.53B | 4.21B | 4.17B | 2.76B |
| Liabilities (USD) | 4.09B | 3.81B | 4.08B | 3.83B | 4.18B | 4.37B | 3.51B | 3.55B | 3.75B | 3.53B | 24.46B | 13.54B | 12.22B | 13.86B | 12.98B | 7.97B |
| Other Non-current Assets (USD) | 2.43B | 2.80B | 3.69B | 3.09B | 4.29B | 4.26B | 3.62B | 3.51B | 4.70B | 6.02B | 26.29B | 17.99B | 17.10B | 16.87B | 15.74B | 10.58B |
| Intangible Assets (USD) | 974.00M | 1.21B | 1.71B | 1.90B | 2.32B | 2.50B | 2.18B | 2.42B | 2.80B | 2.96B | 11.27B | 7.37B | 6.25B | 6.34B | 5.84B | 2.66B |
| Fixed Assets (USD) | - | - | - | 761.00M | 773.00M | 791.00M | 802.40M | 870.60M | 876.00M | 799.80M | 2.83B | 2.20B | 2.21B | 2.14B | 2.10B | 1.14B |
| Noncurrent Assets (USD) | 3.41B | 4.01B | 5.40B | 5.75B | 7.38B | 7.55B | 6.60B | 6.80B | 8.37B | 9.77B | 40.39B | 27.56B | 25.56B | 25.35B | 23.68B | 14.37B |
| Other Current Assets (USD) | 1.24B | 1.06B | 1.24B | 1.16B | 1.24B | 1.25B | 1.36B | 1.29B | 1.38B | 1.37B | 5.74B | 7.60B | 7.33B | 5.77B | 4.49B | 4.23B |
| Prepaid Expenses (USD) | 140.00M | 121.00M | 113.00M | 104.00M | 89.00M | 79.00M | 81.30M | - | - | - | - | - | - | - | - | - |
| Inventory (USD) | 642.00M | 564.00M | 624.00M | 627.00M | 504.00M | 466.00M | 561.70M | 598.90M | 623.10M | 517.10M | 2.10B | 1.83B | 1.78B | 1.81B | 1.78B | 993.02M |
| Current Assets (USD) | 2.02B | 1.75B | 1.97B | 1.89B | 1.84B | 1.79B | 2.00B | 1.89B | 2.00B | 1.88B | 7.84B | 9.43B | 9.11B | 7.59B | 6.27B | 5.22B |
| Assets (USD) | 5.43B | 5.75B | 7.37B | 7.64B | 9.22B | 9.34B | 8.60B | 8.69B | 10.37B | 11.66B | 48.22B | 36.99B | 34.67B | 32.94B | 29.95B | 19.60B |
News and Insights
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.
The global sleeping bruxism treatment market is projected to grow from USD 652.14 million in 2025 to USD 1,132.09 million by 2033, expanding at a 7.18% CAGR. Growth is driven by rising awareness of sleep disorders, increasing stress levels, and demand for oral appliances and behavioral therapies. Occlusal splints and night guards dominate the market, while biofeedback therapy devices represent the fastest-growing segment. North America leads with 40% market share, while Asia Pacific is expected to grow fastest at 9.25% CAGR.
The global dental fillings market is projected to grow from $8.28 billion in 2026 to $13.84 billion by 2032, expanding at a CAGR of 8.65%. Growth is driven by material innovation, digital dentistry integration, advanced restorative solutions, and sustainability initiatives, with key opportunities in aesthetic improvements and regulatory compliance.
The global dental equipment market is projected to grow from USD 6.97 billion in 2024 to USD 17.68 billion by 2032, expanding at a CAGR of 12.35%. Growth is driven by increasing demand for digital dentistry solutions, rising prevalence of dental disorders, and advancements in imaging technologies. However, high equipment costs, regulatory challenges, and a limited skilled workforce present significant restraints to market expansion.
The AI-based caries detection market is projected to grow from $0.62 billion in 2025 to $1.11 billion by 2029 at a 15.6% CAGR, driven by rising dental disease prevalence, aging populations, and increased preventive dentistry adoption. Key innovations include VideaHealth's Caries 3 model and partnerships like Dentalcorp's integration of AI detection technology. However, U.S. tariffs and trade tensions are pressuring margins in the medical equipment sector.
The global dental anesthetics market is projected to grow from $1.48 billion in 2025 to $1.80 billion by 2030, driven by rising oral health awareness, technological innovations, and increasing dental care needs in emerging markets.
The global dental prosthetics market is projected to grow from $4.18B in 2025 to $7.43B by 2032, driven by technological advancements, an aging population, and rising demand for aesthetic dentistry. Key players include Dentsply Sirona and Straumann.
Dentsply Sirona, a leading dental products manufacturer, has priced a $550 million offering of 8.375% junior subordinated notes due 2055. The company plans to use the proceeds to repay existing indebtedness.
Dentsply Sirona Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.